CHAMPIONS ONCOLOGY, INC.
Financial highlights
| Metric | FY April 30, 2025 | FY April 30, 2024 | FY April 30, 2023 | FY April 30, 2022 | FY April 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $56.9M | $50.2M | $53.9M | $49.1M | $41.0M |
| Operating income | $4.6M | -$7.4M | -$5.3M | $607,000 | $366,000 |
| Cost of revenue | $28.4M | $29.4M | $29.5M | $23.6M | $21.4M |
| Cash from operations | $7.4M | -$6.1M | $4.0M | $6.5M | -$1.7M |
| Capital expenditure | $389,000 | $836,000 | $2.9M | $2.4M | $3.3M |
| Free cash flow | $7.0M | -$7.0M | $1.1M | $4.1M | -$5.0M |
| Share repurchases | $0 | $634,000 | $74,000 | $0 | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $32.3M | $26.1M | $34.3M | $35.4M | $27.6M |
| Total liabilities | $28.6M | $28.0M | $29.7M | $26.3M | $20.2M |
Shares outstanding 13.9M · Free float 53.3%
Annual filing data through FY ended April 30, 2025; float as of July 8, 2026.